Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 3 EP applications Alain Henri Werner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 14, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12798331

1,3,5 -TRIAZINE-2-AMINE DERIVATIVES, PREPARATION THEREOF AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/53, C07D 413/04, C07D 409/04, C07D 405/04, C07D 403/04, C07D 401/04, C07D 251/16, A61P 37/00, A61P 35/00, A61P 25/28, A61P 9/00, A61P 3/00, A61P 1/00
Applicant:
Sanofi, S.A.
Agent:
Alain Henri Werner, Sanofi
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12306087

Use of rifapentine in the treatment and/or prevention of active tuberculosis disease

IPC classification:
A61K 45/06, A61K 31/7036, A61K 31/675, A61K 31/536, A61K 31/513, A61K 31/4965, A61K 31/496, A61K 31/4409, A61K 31/133, A61P 31/18, A61P 31/06
Applicant:
Sanofi, S.A.
Agent:
Alain Henri Werner, Sanofi
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13776739

MACROLIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF

IPC classification:
A61K 31/7052, A61K 31/7048, C07H 15/26, A61P 31/06, A61P 31/04
Applicant:
Sanofi, S.A.
Agent:
Alain Henri Werner, Sanofi
Status:
PATENT GRANTED

Please Sign in to use this feature